Resultados de la búsqueda 421-430 of 24316 for Treatment

  1. Programa de tumores cerebrales - Ensayos clínicos

    The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

  2. Radiología - Ensayos clínicos - Mayo Clinic

    ... treatment responses and predict patient outcomes. Quantitative Assessment of Tumor Ablation. Rochester, Minn. The purpose of this study is to retrospectively ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Breast Cancer: Can We Predict Pathological Complete Response following Neoadjuvant Treatment? Scottsdale/Phoenix, Ariz. This project will investigate whether ...

  4. Hematología - Ensayos clínicos

    ... treatment methods on subjects and their cancer. Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease.

  5. Oncología (médica) - Ensayos clínicos

    A Patient Access Program of Olaratumab for the Continued Treatment of Soft Tissue Sarcoma. Jacksonville, Fla. The purpose of this study is to continue to ...

  6. Hepatitis C antibody test - Mayo Clinic

    See how well hepatitis C treatment is working. Healthcare professionals say that all adults should get an HCV antibody test at least once, even if they feel ...

  7. Radiología - Ensayos clínicos - Mayo Clinic

    ... treatment. A Study of Change in Imaging Biomarkers of Dementia with Lewy ... treatment in patients with recurrent grade 2 or 3 meningioma as measured ...

  8. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... treatment(s), such as surgery, chemotherapy, and/or radiation, and (ii) to collect information about patients, treatments, and the behavior of the ...

  9. Ensayos clínicos - Neurología

    FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...

  10. Oncología (médica) - Ensayos clínicos

    ... treatment measured by treatment-related adverse events, patient-reported outcomes (PROs), and treatment discontinuation in older patients (≥ 65 years) with ...